GBT Announces Participation at the H.C. Wainwright Global Life Sciences Conference
April 03 2018 - 4:05PM
Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced
that it will present at the H.C. Wainwright Global Life Sciences
Conference in Monte Carlo, Monaco on Tuesday, April 10 at 9:00 a.m.
Central European Time.
The presentation will be webcast live and available for replay
from GBT’s website at www.gbt.com in the Investors section.
About GBTGBT is a clinical-stage
biopharmaceutical company determined to discover, develop and
deliver innovative treatments that provide hope to underserved
patient communities. GBT is developing its lead product candidate,
voxelotor, as an oral, once-daily therapy for sickle cell disease.
To learn more, please visit www.gbt.com and follow the company on
Twitter @GBT_news.
Contact Information:Myesha Lacy
(investors)GBT650-351-4730investor@gbt.com
Julie Normart (media)W2O pure415-946-1087media@gbt.com
Global Blood Therapeutics (NASDAQ:GBT)
Historical Stock Chart
From Dec 2024 to Jan 2025
Global Blood Therapeutics (NASDAQ:GBT)
Historical Stock Chart
From Jan 2024 to Jan 2025